SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotransplant(BTRN) -- Ignore unavailable to you. Want to Upgrade?


To: LLCF who wrote (390)8/28/1999 1:12:00 AM
From: RWReeves  Respond to of 1475
 
Introduction to graft engineering:

medscape.com

While not for induction of chimerism for organ transplantation, you can see the principles at work.

There is a group in Israel that has done this for organ transplantation but as far as I know have not yet published.

IMhO: BTRN is on the right track and/but there are others that are also. So a hundred bucks a share is probably out.

Disclosure: I'm in the business (not affiliated with BTRN however) so I'm not at all objective. But I like BTRN and I'm buying on dips (and selling on over-exuberant run-ups). I think long term they may have something Swiss in their future.

RWR